ArticleInternational cancer conference journal2025
Favorable response to nivolumab combined with radiotherapy for retroperitoneal leiomyosarcoma.
Shin Ishihara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it